Table 1.
Descriptive summary of Nucleocapsid antibody level (presumed infection) status dynamically over time.
| Timeline | Negative | Positive | Overall (N = 35) |
|---|---|---|---|
| May 2021 | 27 (81.2%) | 6 (18.8%) | 33 |
| 178.8 [122.9, 409.9] | 2097 [1298, 2499] | 271.5 [139.6, 944.2] | |
| June 2021 | – | – | 31 |
| – | – | 252.8 [102.7, 699.9] | |
| July 2021 | – | – | 32 |
| – | – | 142.2 [68.89, 559.0] | |
| August 2021 | – | – | 28 |
| – | – | 101.9 [56.63, 298.3] | |
| September 2021 | – | – | 28 |
| – | – | 52.72 [28.55, 184.7] | |
| Booster | |||
| November 2021 | 20 (80%) | 5 (20%) | 25 |
| 5986 [3680, 12,030] | 6390 [3806, 8772] | 6216 [3806, 11,730] | |
| December 2021 | 18 (72.0%) | 7 (28%) | 25 |
| 2566 [1660, 8539] | 4877 [1574, 7483] | 2654 [1650, 8340] | |
| January 2022 | 18 (75%) | 6 (25%) | 24 |
| 1444 [1092, 2080] | 1458 [1344, 1883] | 1444[1102, 2020] | |
| February 2022 | – | – | 25 |
| – | – | 2080[1463, 3682] | |
| March 2022 | 11 (44%) | 14 (56%) | 25 |
| 1818 [1247, 2319] | 3629 [1687, 7383] | 2281 [1449, 5040] | |
| April 2022 | 12 (50%) | 12 (50%) | 24 |
| 1204 [974.1, 1627] | 2083 [1378, 5376] | 1571 [1004, 2879] | |
| May 2022 | 11 (50%) | 11 (50%) | 22 |
| 879.5 [698.9, 1205] | 1463 [78,648, 2109] | 1103 [696.9, 1661] | |
Note: The antibody data are reported overall and separately by Nucleocapsid status over time and expressed as median (25th, 75th percentile) in BAU/mL.